Henri H. Versteeg

Department of Hemostasis and Thrombosis, Leiden University Medical Center

Affiliated withLeiden University Medical Center Leiden University Medical Center

Research Area

Biography

Henri H. Versteeg has not added Biography.
If you are Henri H. Versteeg and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 93	2015

Other Publications

Article	Year
VIIa/tissue factor interaction results in a tissue factor cytoplasmic domain-independent activation of protein synthesis, p70, and p90 S6 kinase phosphorylation. The Journal of biological chemistry\| PubMed ID: 12019261	2002
In silico tissue factor analysis: a bit-to-bit comparison. Thrombosis and haemostasis\| PubMed ID: 12624646	2003
Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology\| PubMed ID: 12806611	2003
Tissue factor signal transduction in angiogenesis. Carcinogenesis\| PubMed ID: 12807741	2003
Activation of the canonical beta-catenin pathway by histamine. The Journal of biological chemistry\| PubMed ID: 14563838	2003
Coagulation factors VIIa and Xa inhibit apoptosis and anoikis. Oncogene\| PubMed ID: 14724569	2004
Tissue factor as an evolutionary conserved cytokine receptor: Implications for inflammation and signal transduction. Seminars in hematology\| PubMed ID: 14872439	2004
FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production. Circulation research\| PubMed ID: 15016732	2004
Prostanoids and prostanoid receptors in signal transduction. The international journal of biochemistry & cell biology\| PubMed ID: 15109566	2004
Molecular mechanism of violacein-mediated human leukemia cell death. Blood\| PubMed ID: 15130948	2004
Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 15502877	2004
Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 15585833	2004
Tetrahydroxyquinone induces apoptosis of leukemia cells through diminished survival signaling. Experimental hematology\| PubMed ID: 16459187	2006
Emerging insights in tissue factor-dependent signaling events. Seminars in thrombosis and hemostasis\| PubMed ID: 16479459	2006
Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 16959886	2006
Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry\| PubMed ID: 17002301	2006
Coagulation factor Xa drives tumor cells into apoptosis through BH3-only protein Bim up-regulation. Experimental cell research\| PubMed ID: 17531220	2007
Tissue factor coagulant function is enhanced by protein-disulfide isomerase independent of oxidoreductase activity. The Journal of biological chemistry\| PubMed ID: 17613528	2007
Inhibition of tissue factor signaling suppresses tumor growth. Blood\| PubMed ID: 17901245	2008
Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. BioTechniques\| PubMed ID: 17936938	2007
Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. Journal of cellular and molecular medicine\| PubMed ID: 18363839	2008
High factor VIIa levels do not promote tumor metastasis. Thrombosis and haemostasis\| PubMed ID: 18392341	2008
Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer research\| PubMed ID: 18757438	2008
d-Asb11 is an essential mediator of canonical Delta-Notch signalling. Nature cell biology\| PubMed ID: 18776899	2008
Tissue factor mutated at the allosteric Cys186-Cys209 disulfide bond is severely impaired in decrypted procoagulant activity. Blood\| PubMed ID: 20651086	2010
Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development. Blood\| PubMed ID: 20861457	2010
Tissue factor signaling: a multi-faceted function in biological processes. Frontiers in bioscience (Scholar edition)\| PubMed ID: 21622285	2011
Tissue factor-dependent chemokine production aggravates experimental colitis. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 21717035	2011
Thiol pathways in the regulation of tissue factor prothrombotic activity. Current opinion in hematology\| PubMed ID: 21778880	2011
Complete abolishment of coagulant activity in monomeric disulfide-deficient tissue factor. Blood\| PubMed ID: 21940832	2011
The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood\| PubMed ID: 22065595	2012
Evolutionary conservation of the tissue factor disulfide bonds and identification of a possible oxidoreductase binding motif. Journal of thrombosis and haemostasis : JTH\| PubMed ID: 22066736	2012
Mechanistic view of risk factors for venous thromboembolism. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 22345594	2012
Nonproteolytic properties of murine alternatively spliced tissue factor: implications for integrin-mediated signaling in murine models. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 22481268	2012
Tissue factor isoforms in cancer and coagulation: may the best isoform win. Thrombosis research\| PubMed ID: 22682138	2012
Murine tissue factor coagulant activity is critically dependent on the presence of an intact allosteric disulfide. Haematologica\| PubMed ID: 22801966	2013
Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients. Thrombosis research\| PubMed ID: 23260444	2013
New fundamentals in hemostasis. Physiological reviews\| PubMed ID: 23303912	2013
Acute and severe coagulopathy in adult mice following silencing of hepatic antithrombin and protein C production. Blood\| PubMed ID: 23550037	2013
Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model. PloS one\| PubMed ID: 23637930	2013
Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma. International journal of cancer. Journal international du cancer\| PubMed ID: 23754313	2014
Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 23801760	2013
Epidemiology of cancer-associated venous thrombosis. Blood\| PubMed ID: 23908465	2013
Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity. Journal of the American Society of Nephrology : JASN\| PubMed ID: 24610930	2014
Effects of tumor-expressed coagulation factors on cancer progression and venous thrombosis: is there a key factor? Thrombosis research\| PubMed ID: 24862150	2014